Human rights performance indicators
DISCLOSURE ON MANAGEMENT APPROACH
Goals and performance
Novozymes supports international human rights principles and labor standards. Relevant principles are integrated systematically to ensure that global and local initiatives are mutually supportive. Novozymes' seven minimum standards of human and labor rights are based on the United Nations Universal Declaration of Human Rights and the principles of the UN Global Compact.
For Novozymes’ overall commitment to human rights, please refer to Novozymes’ commitments, social responsibility policy, purchasing policy, people policy, position on human rights, position on diversity and equal opportunities, and position on responsible purchasing.
See also the description of Novozymes’ approach to local social responsibility strategies.
Novozymes' Sustainability Development Board has overall responsiblity for human rights aspects of business activities. At each site an appointed person has specific responsibilities for the particular site. Part of the latter responsibility includes raising awareness and training employees in the minimum standards at the site. This responsibility is delegated to regions and sites to allow for emphasis on the most relevant standards in training and raising awareness at a particular site.
Training and awareness
Each year, the entire organization carries out self-assessments that document how these minimum standards are being met. Novozymes' minimum standards are the same as those used by Novozymes to evaluate its suppliers. Based on the minimum standards, Novozymes also analyzes the human rights performance in connection with new acquisitions.
Security practices at Novozymes do not raise human rights issues.
Monitoring and follow-up
Since 2006 Novozymes’ compliance with these standards has been audited by Novozymes' internal auditor corps. Audit findings are reported internally to Executive Management, and follow-up on corrective actions and implementation of appropriate procedures to address issues are integrated into our audit procedures/system, which is verified by our auditors. Novozymes does not report audit findings externally.
|GRI INDICATOR||REFERENCES AND COMMENTS||STATUS|
|Investment and procurement practices|
Percentage and total number of significant investment agreements that include human rights clauses or that have undergone human rights screening
Novozymes reports partially on this aspect since part of the information is proprietary.
Percentage of significant suppliers and contractors that have undergone screening on human rights and actions taken
Total hours of employee training on policies and procedures concerning aspects of human rights that are relevant to operations, including the percentage of employees trained
It is immaterial for Novozymes to report on the amount of total hours of employee training on policies and procedures concerning aspects of human rights because training and communication of Novozymes' minimum standards are mandatory for all employees. Accordingly, Novozymes reports partially on this aspect.
Total number of incidents of discrimination and actions taken
This indicator is not applicable. See Disclosure on management approach above.
|Freedom of association and collective bargaining|
Operations identified in which the right to exercise freedom of association and collective bargaining may be at significant risk, and actions taken to support these rights
Operations identified as having significant risk for incidents of child labor, and measures taken to contribute to the elimination of child labor
|Forced and compulsory labor|
Operations identified as having significant risk for incidents of forced or compulsory labor, and measures to contribute to the elimination of forced or compulsory labor
Percentage of security personnel trained in the organization’s policies or procedures concerning aspects of human rights that are relevant to operations
Total number of incidents of violations involving rights of indigenous people and actions taken
The aspect is immaterial since it is not an issue to our business. Accordingly, Novozymes reports partially on this aspect.